Versigent logo

Versigent

VGNT | NYSE
Chart Builder DCF Calculator
$41.41
+$0.35 (+0.85%)
Nov 2, 2026, 3:18 PM ET · Market open
TTM
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q4 2024
Dec 31, 2024
Revenue
9.24B 6.8B 4.59B 4.41B 2.13B
Cost of Revenue
8.11B 5.99B 4.02B 3.85B 1.86B
Gross Profit
1.13B 809M 566M 565M 269M
Operating Income
701M 502M 356M 358M 166M
Interest Income
4M 4M 1M 1M 1M
Pretax Income
506M 349M 277M 304M 142M
Net Income
518M 400M 322M 232M 127M
Selling & General & Admin
407M 307M 210M 207M 103M
Research & Development
n/a n/a n/a n/a n/a
Other Expenses
22M n/a n/a n/a n/a
Operating Expenses
429M 307M 210M 207M 103M
Interest Expense
41M 5M n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
8.54B 6.3B 4.23B 4.06B 1.96B
Income Tax Expense
-20M -66M -57M 61M 8M
Shares Outstanding (Basic)
70.9M 70.89M 71.05M 71.05M 71.05M
Shares Outstanding (Diluted)
71.88M 70.89M 71.05M 71.05M 71.05M
EPS (Basic)
7.29 5.63 4.53 3.27 1.79
EPS (Diluted)
7.27 5.63 4.53 3.27 1.79
EBITDA
1.03B 728M 521M 514M 218M
EBIT
744M 551M 405M 407M 166M
Depreciation & Amortization
289M 177M 116M 107M 52M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.